Skip to content

The efficacy and safety of Erbium:YAG laser for treatment of enlarged pores: a pilot study

The efficacy and safety of Erbium:YAG laser for treatment of enlarged pores: a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170410001
Enrollment
Unknown
Registered
2017-04-10
Start date
2015-04-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

enlarged pore enlarged pore Erbium:YAG laser

Interventions

Erbium:YAG laser (fotona)
Experimental Device

Sponsors

none
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: patient with enlarged pores at nose and cheeks

Exclusion criteria

Exclusion criteria: -patient with photosensitivity, acne, infection or inflammation at the study area -smoking -pregnancy and lactation -using any product contain AHA or retinoic acid within 6 months prior to the study period -treated with any laser or radiofrequency within 6 months prior to the study period

Design outcomes

Primary

MeasureTime frame
efficacy of Erbium:YAG laser for treatment of enlarged pores 1 month after 5th treatment, 3 months after 5th treatment, 6 months after 5th treatment pore size measured by UVA-light video camera

Secondary

MeasureTime frame
side effect of Erbium:YAG laser for treatment of enlarged pores immediate after treatment, months after 5th treatment, 6 months after 5th treatment physician assessment

Countries

Thailand

Contacts

Public ContactWeeranut Phothong

Department of dermatology, Faculty of medicine Siriraj Hospital

weeranut@gmail.com024194333

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026